Tesamorelin for Visceral Fat: Clinical Use and Patient Selection

Mechanism of Action in Clinical Settings

Tesamorelin stimulates the pituitary gland to produce and release endogenous growth hormone. This increase in GH levels initiates lipolysis. It specifically reduces visceral fat without significantly affecting subcutaneous fat layers. This distinction is critical for clinics focusing on metabolic health rather than just aesthetics.

• Binds to GHRH receptors in the pituitary
• Increases IGF-1 levels within physiological ranges
• Triggers breakdown of visceral triglycerides
• Preserves lean muscle mass during fat loss

Ideal Patient Profiles

Clinics should prioritize patients with documented excess visceral fat. This is often seen in metabolic syndrome or specific inflammatory conditions. It is not a general weight loss tool for patients with low body fat percentages. Target patients who have reached a plateau with diet and exercise.

• Patients with a high waist-to-hip ratio
• Individuals with metabolic dysfunction
• Patients requiring targeted trunk fat reduction
• Adults with growth hormone deficiency symptoms

When to Avoid Tesamorelin

Screening is mandatory to ensure patient safety. Because Tesamorelin increases growth hormone, it is contraindicated in patients with active malignancies. Growth hormone can accelerate the progression of certain tumors. Always conduct a thorough medical history before starting a cycle.

• Active or recent history of cancer
• Pregnancy or breastfeeding status
• Hypersensitivity to Tesamorelin or mannitol
• Patients with closed epiphyseal plates

Expected Results and Monitoring

Clinical data shows significant reductions in visceral adipose tissue over 26 weeks. Most clinics monitor progress via DEXA scans or waist measurements every 30 days. Providers must watch for changes in glucose metabolism. While rare, some patients may show increased insulin resistance during treatment.

Integrating Tesamorelin into Clinic Protocols

Tesamorelin works best as a daily subcutaneous injection. Compliance is the primary driver of results. Clinics typically offer this as part of a comprehensive longevity or metabolic health program. Pairing it with lean protein intake and resistance training maximizes the impact on body composition.

• Daily administration required for consistency
• Rotate injection sites to avoid irritation
• Standard cycles range from 3 to 6 months
• Apply for wholesale access to stock your clinic